Govt Job: For Pharmacology, Life Sciences Job as Editorial Assistant at PGIMER

The PGIMER owes its inception to the vision of late Sardar Partap Singh Kairon, the then Chief Minister of Punjab, and the distinguished medical educationists of the then combined state of Punjab, supported by the first Prime Minister of India, Pt. Jawahar Lal Nehru, who considered the institutions of scientific knowledge as temples of learning and the places of pilgrimage.

Post : Editorial Assistant (One Post)

Applications are invited on a plain paper for the contractual post of Editorial Assistant in International Journal of Pharmaceutical Sciences and Nanotechnology (IJPSN) by Professor Bikash Medhi, Chief Editor, Department of Pharmacology, PGIMER, Chandigarh-160012. The post is purely on temporary basis.

Qualification :First Class Master’s Degree in Pharmacology / Life-Sciences from a recognized university.

Desirable : Experience in the Research field or scientific writing. Candidates with proficiency in computer application will be preferred

Age : As per GOI rules
Pay Scale : Rs. 35, 000/- per month (consolidated).

The above appointment will be purely on temporary basis. Interested candidates fulfilling the above conditions are required to submit their bio-data and necessary testimonials/ certificates by 6th May, 2022, through email at recruitmentmanpowereplpgimer@gmail.com

The candidates will be scrutinized by the selection committee and only short-listed candidates will be intimated through email/phone to attend the interview through online mode. No Separate interview letters will be sent.

Related Posts

Wegovy, Ozempic regain weight as Indian generics fall behind

Mumbai: Novo Nordisk’s weight-loss GLP-1 drug semaglutide branded as Wegovy and Ozempic are clawing back their lost ground with steady month-on-month sales growth as the frenzy of Indian generics begins…

Drug regulator orders fresh safety labels for five common antimicrobials

The updated warnings are intended to alert doctors and patients to rare but potentially serious reactions that surfaced after the medicines entered widespread clinical use. New Delhi: India’s drug regulator…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Wegovy, Ozempic regain weight as Indian generics fall behind

Wegovy, Ozempic regain weight as Indian generics fall behind

Drug regulator orders fresh safety labels for five common antimicrobials

Drug regulator orders fresh safety labels for five common antimicrobials

Rajasthan recalls labour-inducing drug after quality test failure

Rajasthan recalls labour-inducing drug after quality test failure

‘Made in India’ Surgical Robot SSiMantra makes Powerful Presence felt in UK

‘Made in India’ Surgical Robot SSiMantra makes Powerful Presence felt in UK

Indian nutraceutical industry unites at NUTRAVISION @2047

Indian nutraceutical industry unites at NUTRAVISION @2047

Cancer drugs worth crores flown in as ‘coolant’ from Laos, customs probe flags suspected import route

Cancer drugs worth crores flown in as ‘coolant’ from Laos, customs probe flags suspected import route